Page last updated: 2024-11-02

oxybutynin and Erythema

oxybutynin has been researched along with Erythema in 8 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Research Excerpts

ExcerptRelevanceReference
"Using Medline, Embase, and the Science Citation Index, we summarize the cutaneous adverse effects of transdermal and parenteral fentanyl."2.46Fentanyl transdermal patches: overview of cutaneous adverse effects in humans. ( Hostynek, JJ; Maibach, HI, 2010)
"Localized neuropathic pain (LNP) is a subgroup of neuropathic pain characterized by consistent and circumscribed area(s) of maximum pain, associated with negative or positive sensory signs and/or spontaneous symptoms characteristic of NP."1.48Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy. ( Chinellato, E; Del Balzo, G; Martini, A; Parolini, M; Picelli, A; Polati, E; Schweiger, V; Tamburin, S; Zanzotti, M, 2018)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's3 (37.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Chancellor, M1
Ruan, J1
Liu, C1
Wang, J1
Zhong, T1
Quan, P1
Fang, L1
Park, JH2
Kim, CB1
Lee, HJ1
Roh, JY1
Lee, JM1
Kim, HJ1
Muller, DA1
Henricson, J1
Baker, SB1
Togö, T1
Jayashi Flores, CM1
Lemaire, PA1
Forster, A1
Anderson, CD1
Martini, A1
Del Balzo, G1
Schweiger, V1
Zanzotti, M1
Picelli, A1
Parolini, M1
Chinellato, E1
Tamburin, S1
Polati, E1
Bermejo, PE1
Zea, MA1
Alba-Alcántara, L1
Ruiz-Huete, C1
Hostynek, JJ1
Maibach, HI1
HOLLE, F1

Reviews

1 review available for oxybutynin and Erythema

ArticleYear
Fentanyl transdermal patches: overview of cutaneous adverse effects in humans.
    Cutaneous and ocular toxicology, 2010, Volume: 29, Issue:4

    Topics: Analgesics, Opioid; Dermatitis, Allergic Contact; Dermatitis, Irritant; Erythema; Female; Fentanyl;

2010

Trials

1 trial available for oxybutynin and Erythema

ArticleYear
Innate local response and tissue recovery following application of high density microarray patches to human skin.
    Scientific reports, 2020, 10-28, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; Epidermis; Erythema; Humans; Male; Middle Aged; Transdermal Patch; Vaccinat

2020

Other Studies

6 other studies available for oxybutynin and Erythema

ArticleYear
Transdermal oxybutynin. A viewpoint by Michael Chancellor.
    Drugs & aging, 2003, Volume: 20, Issue:11

    Topics: Administration, Cutaneous; Delayed-Action Preparations; Erythema; Humans; Mandelic Acids; Pruritus;

2003
Efficacy and safety of permeation enhancers: A kinetic evaluation approach and molecular mechanism study in the skin.
    International journal of pharmaceutics, 2022, Oct-15, Volume: 626

    Topics: Administration, Cutaneous; Erythema; Humans; Permeability; Skin; Skin Absorption; Transdermal Patch

2022
Development and clinical study of the use of infrared radiation to accelerate the dissolution rate of a microneedle array patch (MAP).
    Drug delivery and translational research, 2020, Volume: 10, Issue:3

    Topics: Adult; Erythema; Female; Humans; Hyaluronic Acid; Infrared Rays; Male; Microinjections; Solubility;

2020
Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
    Minerva medica, 2018, Volume: 109, Issue:5

    Topics: Aged; Analgesics; Anesthetics, Local; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; E

2018
[Local effects of transdermal treatment with rotigotine].
    Revista de neurologia, 2013, Apr-01, Volume: 56, Issue:7

    Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Drug Evaluation; Drug Therapy, Combination; Equipment

2013
[Patch ultraviolet irradiation as demonstration of effective desympathization].
    Arztliche Wochenschrift, 1954, Jan-15, Volume: 9, Issue:3

    Topics: Erythema; Humans; Transdermal Patch; Ultraviolet Rays; Ultraviolet Therapy

1954